Vitamin C and D Supplements to Prevent the Risk of COVID-19

Author:

Shahrajabian Mohamad Hesam1,Sun Wenli1,Cheng Qi2

Affiliation:

1. Biotechnology Research Institute, Chinese Academy of Agricultural Sciences, Beijing 100081, China

2. College of Life Sciences, Hebei Agricultural University, Baoding, Global Alliance of HeBAU-CLS&HeQiS for BioAl-Manufacturing, Baoding, Hebei 071000, China

Abstract

Background: Virus is a tiny agent, around one-hundredth the size of a bacterium which can infect cells of plants and animals. Seven coronaviruses are known to infect humans, three of them are serious, namely, SARS (severe acute respiratory syndrome, China, 2002), MERS (Middle East respiratory syndrome, Saudi Arabia, 2012), and SARS-CoV-2 (COVID-19) (2019-2020).SARS-CoV, and MERS-CoV belong to betacoronaviruses (betaCoVs). Objective: In this mini review, we want to consider the important vitamin D and C, especially plants containing these two vitamins in fight against COVID-19. Methods: The manuscript includes review articles, randomized control experiments, analytical studies and observations, which have been gathered from different sources such as Google Scholar, Scopus, Science Direct and PubMed. A review of the literature was carried out using the keywords such as vitamin D, vitamin C, COVID-19, influenza, Plant, and Coronaviruses. Results: Various sources of vitamin D for humans are food, dietary supplements and the skin by exposure to 7-dehydrocholesterol to ultraviolet light. There are some new findings on influence vitamin D in prevent and control of influenza and COVID-19. Vitamin D may play roles in preventing influenza and covid-19 by production of large quantities of IL-1 and IL-6, or modulating the production of the interleukins. Conclusion: Vitamin D deficiency is a potential link between respiratory infection and immune evasion, and vitamin D is a pleiotropic factor known to modulate immune response against pathogen.

Funder

National Key R&D Program of China

Publisher

Bentham Science Publishers Ltd.

Subject

Complementary and alternative medicine,Drug Discovery

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3